Similarly, the NT-TBI group also exhibited a significant MAP2 neuronal cell loss in the cortex (53.13±7.19 neurons/ HPF) compared to the AD-Sham group (p<0.01) and NT-Sham group (p<0.01). This evidence concerns the gene MAP2 and Alzheimer disease.